跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 64,668 条关于
“GLP-1/GIP”
全部
64,668
临床试验
39,922
药物
7,849
机构
1,456
资讯
15,441
去年
Hengrui and Kailera Present Phase 2 Data for Dual GLP-1/GIP Agonist and Oral GLP-1 Therapies at ADA 2025
11个月前
Chugai Licenses Roche's CT-388 Dual GLP-1/GIP Receptor Agonist for Japan Market
上个月
Neurocrine Biosciences Launches Phase I Trial of GLP-1/GIP/Glucagon Triple Agonist NBIP-1968 for Obesity
去年
Regeneron Licenses Chinese GLP-1/GIP Dual Agonist in $2 Billion Obesity Deal with Hansoh Pharma
去年
Palatin Technologies Completes Enrollment in Phase 2 Obesity Trial of Bremelanotide and Tirzepatide Combination
去年
American Heart Association Awards $1M to Study GLP-1 Medications' Impact on Cardiovascular Risk
去年
Viking Therapeutics Advances Novel Oral GLP-1/GIP Dual Agonist VK2735 to Phase 2 Trial for Obesity Treatment
去年
Kailera Therapeutics Launches with $400M to Advance GLP-1 Based Obesity Therapies
去年
Palatin Technologies Completes Enrollment in Phase 2 Obesity Trial of Bremelanotide with Tirzepatide
5个月前
BrightGene's Oral GLP-1/GIP Dual Agonist BGM0504 Shows Promising Weight Loss Results in Phase 1 Trials
第 1 页,共 1545 页
上一页
下一页